Acute systemic reaction and lung alterations induced by an antiplatelet integrin gpIIb/IIIa antibody in mice

Blood

Volumn 94, Issue 2, 1999, Pages 684-693

  Nieswandt, Bernhard ^b   Echtenacher, Bernd ^b   Wachs, Frank Peter ^b   Schröder, Josef ^b   Gessner, J Engelbert ^b   Schmidt, Reinhold E ^b   Grau, Georges E ^b   Männel, Daniela N ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FC RECEPTOR; FIBRINOGEN RECEPTOR; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; THROMBOCYTE ANTIBODY; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; HYPOTHERMIA; LUNG CONGESTION; LUNG INJURY; LUNG INTERSTITIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHOCK; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

EID: 0033566304     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.2.684.414k36_684_693     Document Type: Article

References (50)

1. Piguet PF, Vesin C, Ryser JE, Senaldi G, Grau GE, Tacchini Cottier F: An effector role for platelets in systemic and local lipopolysaccharide-induced toxicity in mice, mediated by a CD11a-and CD54-dependent interaction with endothelium. Infect Immunity 61:4182, 1993
2. Grau GE, Tacchini Cottier F, Vesin C, Milon G, Lou JN, Piguet PF, Juillard P, Ryser JE, Senaldi G: TNF-induced microvascular pathology: Active role for platelets and importance of the LFA-1/ICAM-1 interaction. An effector role for platelets in systemic and local lipopolysaccharide-induced toxicity in mice, mediated by a CD11 a- and CD54-dependent interaction with endothelium. Eur Cytokine Netw 61:4182, 1993
3. Pearson JM, Schultze AE, Jean PA, Roth RA: Platelet participation in liver injury from gram-negative bacterial lipopolysaccharide in the rat. Shock 4:178, 1995
4. Kuroda T, Shiohara E: Leukocyte and platelet depletion protects the liver from damage induced by cholestasis and ischemia-reperfusion in the dog. Scand J Gastroenterol 31:182, 1996
5. Männel DN, Grau GE: Role of platelet adhesion in homeostasis and immunopathology. Mol Pathol 50:175, 1997
6. McCall CE, DeChatelet LR, Cooper MR, Shannon C: Human toxic neutrophils. 3. Metabolic characteristics. J Infect Dis 127:26, 1973
7. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, Ambruso DR: Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 101:1458, 1998
8. Salzer WL, McCall CE: Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury. J Clin Invest 85:1135, 1990
9. Camussi G, Bussolino F, Salvidio G, Baglioni C: Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorpho-nuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 166:1390, 1987
10. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A: Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol 93:707, 1996
11. Beutler B, Grau GE: Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 21:S423, 1993
12. Tracey KJ, Cerami A: Tumor necrosis factor: An updated review of its biology. Crit Care Med 21:S415, 1993
13. Tracey KJ, Cerami A: Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491, 1994
14. Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Bruining HA, Otto C, Tobin E, Zwingelstein C, Lesslauer W, Leighton A: p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA 277:1531, 1997
15. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334:1697, 1996
16. Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ, Kinet JP: Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest 99:915, 1997
17. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ: Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1 -dependent passive anaphylaxis. J Clin Invest 99:901, 1997
18. Höpken UE, Lu B, Gerard NP, Gerard C: Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J Exp Med 186:749, 1997
19. Hazenbos WL, Gessner JE, Hofhuis FM, Kuipers H, Meyer D, Heijnen IA, Schmidt RE, Sandor M, Capel PJ, Daeron M, van de Winkel JG, Verbeek JS: Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice. Immunity 5:181, 1996
20. Pierres M, Goridis C, Golstein P: Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol 12:60, 1982
21. Prieto J, Takei F, Gendelman R, Christenson B, Biberfeld P, Patarroyo M: MALA-2, mouse homologue of human adhesion molecule ICAM-1 (CD54). Eur J Immunol 19:1551, 1989
22. Lopez AF, Strath M, Sanderson CJ: Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br J Haematol 57:489, 1984
23. Unkeless JC: Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 150:580, 1979
24. Burstein SA, Friese P, Downs T, Mei RL: Characteristics of a novel rat anti-mouse platelet monoclonal antibody: Application to studies of megakaryocytes. Exp Hematol 20:1170, 1992
25. Mahalingan M, Ugen KE, Kao KJ, Klein PA: Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants. Cancer Res 48:1460, 1988
26. Rehli M, Krause SW, Kreutz M, Andreesen R: Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation. J Biol Chem 270:15644, 1995
27. Law DA, Nannizzi Alaimo L, Phillips DR: Outside-in integrin signal transduction. Alpha lib beta 3-(GP IIb IIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol Chem 271:10811, 1996
28. Cieutat AM, Rosa JP, Letourneur F, Poncz M, Rifat S: A comparative analysis of cDNA-derived sequences for rat and mouse beta 3 integrins (GPIIIA) with their human counterpart. Biochem Biophys Res Commun 193:771, 1993
29. Poncz M, Newman PJ: Analysis of rodent platelet glycoprotein IIb: Evidence for evolutionarily conserved domains and alternative proteolytic processing. Blood 75:1282, 1990
30. Bauss F, Dröge W, Männel DN: Tumor necrosis factor mediates endotoxic effects in mice. Infect Immunity 55:1622, 1987
31. Rietschel ET, Brade H, Holst O, Brade L, Muller Loennies S, Mamat U, Zähringer U, Beckmann F, Seydel U, Brandenburg K, Ulmer AJ, Mattern T, Heine H, Schletter J, Loppnow H, Schönbeck U, Flad HD, Hauschildt S, Schade UF, Di Padova F, Kusumoto S, Schumann RR: Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 216:39, 1996
32. De Reys S, Blom C, Lepoudre B, Declerck PJ, De Ley M, Vermylen J, Deckmyn H: Human platelet aggregation by murine monoclonal antiplatelet antibodies is subtype-dependent. Blood 81: 1792, 1993
33. Du X, Ginsberg MH: Integrin alpha lib beta 3 and platelet function. Thromb Haemost 78:96, 1997
34. Horsewood P, Hayward CP, Warkentin TE, Kelton JG: Investigation of the mechanisms of monoclonal antibody-induced platelet activation. Blood 78:1019, 1991
35. Lindahl TL, Larsson A: C1q binding to platelets induced by monoclonal antibodies and immune complexes - A flow cytometric analysis. Platelets 4:73, 1993
36. Larsson A, Egberg N, Lindahl TL: Platelet activation and binding of complement components to platelets induced by immune complexes. Platelets 5:149, 1994
37. Rosenfeld SI, Ryan DH, Looney RJ, Anderson CL, Abraham GN, Leddy JP: Human Fc gamma receptors: Stable inter-donor variation in quantitative expression on platelets correlates with functional responses. J Immunol 138:2869, 1987
38. Clynes R, Ravetch JV: Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 3:21, 1995
39. Brouckaert P, Libert C, Cauwels A, Everaerdt B, Van Molle W, Ameloot P, Gansemans Y, Grijalba B, Takahashi N, Truong MJ, Van Leuven P, Fiers W: Inhibition of and sensitization to the lethal effects of tumor necrosis factor. J Inflammation 47:18, 1995
40. Rothstein JL, Schreiber H: Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci USA 85:607, 1988
41. Everaerdt B, Brouckaert P, Shaw A, Fiers W: Four different interleukin-1 species sensitize to the lethal action of tumour necrosis factor. Biochem Biophys Res Commun 163:378, 1989
42. McCuskey RS, Urbaschek R, Urbaschek B: The microcirculation during endotoxemia. Cardiovasc Res 32:752, 1996
43. Blumenstein M, Boekstegers P, Fraunberger P, Andreesen R, Ziegler-Heitbrock HW, Fingerle Rowson G: Cytokine production precedes the expansion of CD14+CD16+ monocytes in human sepsis: A case report of a patient with self-induced septicemia. Shock 8:73, 1997
44. Ziegler-Heitbrock HW: Molecular mechanism in tolerance to lipopolysaccharide. J Inflammation 45:13, 1995
45. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782, 1996
46. Wang C, Mayo MW, Baldwin AS: TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274:784, 1996
47. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787, 1996
48. Gans RO, DiPirro JC, Ueda Y, Niesen N, Lee KH, Brentjens JR: The effect of SRI 63-675, a competitive platelet-activating factor receptor-antagonist, in the generalized Shwartzman reaction. J Lipid Mediat Cell Signal 10:229, 1994
49. Rabinovici R, Esser KM, Lysko PG, Yue T, Griswold DE, Hillegass LM, Bugelski PJ, Hallenbeck JM, Feuerstein G: Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock. Circ Res 69:12, 1991
50. Grau GE, Männel DN: TNF inhibition and sepsis - Sounding a cautionary note. Nat Med 3:1193, 1997